Noxopharm Limited (NOX.AX)
AUD 0.09
(-1.06%)
AUD 0.09
(-1.06%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -7.53 Million AUD | 54.59% |
| 2023 | -16.59 Million AUD | -9.12% |
| 2022 | -15.2 Million AUD | -4.09% |
| 2021 | -14.6 Million AUD | 10.73% |
| 2020 | -16.36 Million AUD | -4.47% |
| 2019 | -15.66 Million AUD | -49.19% |
| 2018 | -10.5 Million AUD | -224.12% |
| 2017 | -3.23 Million AUD | -360.79% |
| 2016 | -703.07 Thousand AUD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -7 Million AUD | 57.81% |
| 2024 Q4 | -3.82 Million AUD | 0.0% |
| 2024 Q2 | -3.47 Million AUD | 0.0% |
| 2023 Q2 | -8.96 Million AUD | 0.0% |
| 2023 Q4 | -7.62 Million AUD | 0.0% |
| 2023 FY | -16.59 Million AUD | -9.12% |
| 2022 FY | -15.2 Million AUD | -4.09% |
| 2022 Q2 | -6.53 Million AUD | 0.0% |
| 2022 Q4 | -8.67 Million AUD | 0.0% |
| 2021 Q2 | -7.45 Million AUD | 0.0% |
| 2021 FY | -14.6 Million AUD | 10.73% |
| 2021 Q4 | -8.45 Million AUD | 0.0% |
| 2020 Q2 | -9.74 Million AUD | 0.0% |
| 2020 FY | -16.36 Million AUD | -4.47% |
| 2020 Q4 | -6.62 Million AUD | 0.0% |
| 2019 Q4 | -8.17 Million AUD | 0.0% |
| 2019 FY | -15.66 Million AUD | -49.19% |
| 2019 Q2 | -4.22 Million AUD | 0.0% |
| 2018 Q4 | -5.55 Million AUD | 0.0% |
| 2018 FY | -10.5 Million AUD | -224.12% |
| 2018 Q2 | -4.02 Million AUD | 0.0% |
| 2017 Q3 | -761.47 Thousand AUD | 34.3% |
| 2017 FY | -3.23 Million AUD | -360.79% |
| 2017 Q2 | -1.15 Million AUD | 0.0% |
| 2017 Q4 | -1.94 Million AUD | -155.17% |
| 2016 Q2 | - AUD | 0.0% |
| 2016 Q3 | - AUD | 0.0% |
| 2016 Q4 | - AUD | 0.0% |
| 2016 FY | -703.07 Thousand AUD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 9.71 Million AUD | 177.548% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -416.405% |
| Zelira Therapeutics Limited | -5.93 Million AUD | -26.89% |
| Biome Australia Limited | -1.91 Million AUD | -293.835% |
| Patrys Limited | -3.53 Million AUD | -112.904% |
| Orthocell Limited | -11.68 Million AUD | 35.494% |
| Imugene Limited | -140.93 Million AUD | 94.653% |
| PYC Therapeutics Limited | -38.85 Million AUD | 80.608% |
| Chimeric Therapeutics Limited | -12.3 Million AUD | 38.788% |
| Prescient Therapeutics Limited | -7.18 Million AUD | -4.851% |
| Proteomics International Laboratories Limited | -7.23 Million AUD | -4.196% |
| Cynata Therapeutics Limited | -8.8 Million AUD | 14.452% |
| CSL Limited | 5.64 Billion AUD | 100.133% |
| Arovella Therapeutics Limited | -7.19 Million AUD | -4.754% |
| Bio-Gene Technology Limited | -3.06 Million AUD | -146.044% |
| Clinuvel Pharmaceuticals Limited | 49.14 Million AUD | 115.331% |
| Starpharma Holdings Limited | -15.15 Million AUD | 50.294% |
| Nanollose Limited | -1.24 Million AUD | -502.885% |
| Memphasys Limited | -2.7 Million AUD | -178.661% |
| Invex Therapeutics Ltd | -2.13 Million AUD | -253.155% |
| NeuroScientific Biopharmaceuticals Limited | -2.05 Million AUD | -266.389% |
| Amplia Therapeutics Limited | -4.42 Million AUD | -70.284% |
| Botanix Pharmaceuticals Limited | -14.69 Million AUD | 48.741% |
| Island Pharmaceuticals Limited | -2.87 Million AUD | -162.198% |
| Race Oncology Limited | -13.38 Million AUD | 43.687% |
| Nyrada Inc. | -4.56 Million AUD | -65.229% |
| Telix Pharmaceuticals Limited | - AUD | Infinity% |
| Dimerix Limited | -25.05 Million AUD | 69.932% |
| PharmAust Limited | -6.65 Million AUD | -13.161% |
| Immutep Limited | -44.93 Million AUD | 83.232% |
| Clarity Pharmaceuticals Ltd | -44.8 Million AUD | 83.181% |
| Alterity Therapeutics Limited | -19.6 Million AUD | 61.559% |
| BTC Health Limited | 1.05 Million AUD | 814.024% |
| Acrux Limited | -9.83 Million AUD | 23.378% |
| Neuren Pharmaceuticals Limited | 225.96 Million AUD | 103.335% |
| Biotron Limited | -5.15 Million AUD | -46.277% |
| Tissue Repair Ltd | -4.87 Million AUD | -54.534% |
| AdAlta Limited | -5.26 Million AUD | -43.208% |
| Radiopharm Theranostics Limited | -47.2 Million AUD | 84.039% |
| Hexima Limited | -1 Million AUD | -646.964% |
| AnteoTech Limited | -11.72 Million AUD | 35.744% |
| Paradigm Biopharmaceuticals Limited | -65.11 Million AUD | 88.428% |
| Recce Pharmaceuticals Ltd | -22.05 Million AUD | 65.83% |
| Avecho Biotechnology Limited | -4.58 Million AUD | -64.19% |
| Actinogen Medical Limited | -12.83 Million AUD | 41.312% |
| Immuron Limited | -5.8 Million AUD | -29.889% |
| Argenica Therapeutics Limited | -5.67 Million AUD | -32.864% |